Malin-backed Poseida Therapeutics files for IPO on Nasdaq exchange
Poseida is one of four priority assets in which the life sciences company has stakes
Life sciences firm Malin acquires 33% of Wren Therapeutics
Company has option to increase shareholding to 67% under terms of transaction
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices